{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:18:23Z","timestamp":1757618303085,"version":"3.44.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s13318-025-00954-3","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T14:01:18Z","timestamp":1750168878000},"page":"371-381","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tacrolimus Trough Concentrations are Not Impacted by Epstein\u2013Barr Virus Serology and Viral Load in Pediatric Liver Transplant Recipients"],"prefix":"10.1007","volume":"50","author":[{"given":"Amber M.","family":"te Lintelo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa F.","family":"van Wier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert P. J.","family":"van der Doef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos G. W.","family":"Kosterink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"Scheenstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coretta C.","family":"van Leer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arno R.","family":"Bourgonje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daan J.","family":"Touw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3551-1201","authenticated-orcid":false,"given":"Paola","family":"Mian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"issue":"6","key":"954_CR1","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3748\/WJG.15.648","volume":"15","author":"M Spada","year":"2009","unstructured":"Spada M, Riva S, Maggiore G, Cintorino D, Gridelli B. Pediatric liver transplantation. World J Gastroenterol: WJG. 2009;15(6):648. https:\/\/doi.org\/10.3748\/WJG.15.648.","journal-title":"World J Gastroenterol: WJG"},{"key":"954_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/J.JPEDS.2017.11.015","volume":"196","author":"DB Mogul","year":"2018","unstructured":"Mogul DB, Luo X, Bowring MG, et al. Fifteen-year trends in pediatric liver transplants: split, whole deceased, and living donor grafts. J Pediatr. 2018;196:148-153.e2. https:\/\/doi.org\/10.1016\/J.JPEDS.2017.11.015.","journal-title":"J Pediatr"},{"issue":"4","key":"954_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1053\/J.SEMPEDSURG.2017.07.014","volume":"26","author":"AG Cuenca","year":"2017","unstructured":"Cuenca AG, Kim HB, Vakili K. Pediatric liver transplantation. Semin Pediatr Surg. 2017;26(4):217\u201323. https:\/\/doi.org\/10.1053\/J.SEMPEDSURG.2017.07.014.","journal-title":"Semin Pediatr Surg"},{"issue":"1","key":"954_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jhep.2005.10.009","volume":"44","author":"JF Dufour","year":"2006","unstructured":"Dufour JF, Fey MF. What is the current treatment of PTLD after liver transplantation? J Hepatol. 2006;44(1):23\u20136. https:\/\/doi.org\/10.1016\/j.jhep.2005.10.009.","journal-title":"J Hepatol"},{"issue":"S3","key":"954_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1002\/lt.22410","volume":"17","author":"RH Wiesner","year":"2011","unstructured":"Wiesner RH, Fung JJ. Present state of immunosuppressive therapy in liver transplant recipients. Liver Transpl. 2011;17(S3):S1\u20139. https:\/\/doi.org\/10.1002\/lt.22410.","journal-title":"Liver Transpl"},{"key":"954_CR6","unstructured":"Araya AA, Tasnif Y. Tacrolimus. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing 2025."},{"issue":"4","key":"954_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2165\/00003088-200140040-00004","volume":"40","author":"PE Wallemacq","year":"2001","unstructured":"Wallemacq PE, Verbeeck RK. Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients. Clin Pharmacokinet. 2001;40(4):283\u201395. https:\/\/doi.org\/10.2165\/00003088-200140040-00004.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"954_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","volume":"41","author":"M Brunet","year":"2019","unstructured":"Brunet M, Van Gelder T, \u00c5sberg A, et al. Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report. Ther Drug Monit. 2019;41(3):261\u2013307. https:\/\/doi.org\/10.1097\/FTD.0000000000000640.","journal-title":"Ther Drug Monit"},{"issue":"5","key":"954_CR9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0090-9556(25)08793-8","volume":"20","author":"M Sattler","year":"1992","unstructured":"Sattler M, Guengerich FP, Yun CH, Christians U, Sewing KF. Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. Drug Metab Dispos. 1992;20(5):753\u201361.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"954_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2133\/DMPK.DMPK-11-RV-111","volume":"27","author":"K Kurose","year":"2012","unstructured":"Kurose K, Sugiyama E, Saito Y. Population differences in major functional polymorphisms of pharmacokinetics\/pharmacodynamics-related genes in eastern Asians and Europeans: implications in the clinical trials for novel drug development. Drug Metab Pharmacokinet. 2012;27(1):9\u201354. https:\/\/doi.org\/10.2133\/DMPK.DMPK-11-RV-111.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"4","key":"954_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/S41397-019-0144-7","volume":"20","author":"AR Khan","year":"2020","unstructured":"Khan AR, Raza A, Firasat S, Abid A. CYP3A5 gene polymorphisms and their impact on dosage and trough concentration of tacrolimus among kidney transplant patients: a systematic review and meta-analysis. Pharmacogenom J. 2020;20(4):553\u201362. https:\/\/doi.org\/10.1038\/S41397-019-0144-7.","journal-title":"Pharmacogenom J"},{"issue":"9","key":"954_CR12","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.2217\/PGS.14.75","volume":"15","author":"V Guy-Viterbo","year":"2014","unstructured":"Guy-Viterbo V, Baudet H, Elens L, et al. Influence of donor-recipient CYP3A4\/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach. Pharmacogenomics. 2014;15(9):1207\u201321. https:\/\/doi.org\/10.2217\/PGS.14.75.","journal-title":"Pharmacogenomics"},{"issue":"5","key":"954_CR13","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/J.TRANSPROCEED.2008.04.010","volume":"40","author":"PT Loh","year":"2008","unstructured":"Loh PT, Lou HX, Zhao Y, Chin YM, Vathsala A. Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients. Transplant Proc. 2008;40(5):1690\u20135. https:\/\/doi.org\/10.1016\/J.TRANSPROCEED.2008.04.010.","journal-title":"Transplant Proc"},{"issue":"6","key":"954_CR14","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2165\/00003088-199937060-00004","volume":"37","author":"SN De Wildt","year":"1999","unstructured":"De Wildt SN, Kearns GL, Leeder JS, Van Den Anker JN. Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet. 1999;37(6):485\u2013505. https:\/\/doi.org\/10.2165\/00003088-199937060-00004.","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"954_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/GENES11121509","volume":"11","author":"LM de Jong","year":"2020","unstructured":"de Jong LM, Jiskoot W, Swen JJ, Manson ML. Distinct effects of inflammation on cytochrome P450 regulation and drug metabolism: lessons from experimental models and a potential role for pharmacogenetics. Genes (Basel). 2020;11(12):1\u201324. https:\/\/doi.org\/10.3390\/GENES11121509.","journal-title":"Genes (Basel)"},{"key":"954_CR16","doi-asserted-by":"publisher","unstructured":"Green M, Michaels MG. Epstein\u2013Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant. 2013;13 Suppl 3(SUPPL. 3):41\u201354. https:\/\/doi.org\/10.1111\/AJT.12004.","DOI":"10.1111\/AJT.12004"},{"issue":"3","key":"954_CR17","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/HEP.32223","volume":"75","author":"J de Ville de Goyet","year":"2022","unstructured":"de Ville de Goyet J, Baumann U, Karam V, et al. European Liver Transplant Registry: donor and transplant surgery aspects of 16,641 liver transplantations in children. Hepatology. 2022;75(3):634\u201345. https:\/\/doi.org\/10.1002\/HEP.32223.","journal-title":"Hepatology"},{"key":"954_CR18","unstructured":"Kennisbank KNMP-Tacrolimus. https:\/\/kennisbank-beta.knmp.nl\/article\/Informatorium_Medicamentorum\/S2538.html"},{"key":"954_CR19","doi-asserted-by":"publisher","unstructured":"Nowalk A, Green M. Epstein\u2013Barr virus. In: Hayden RT, Wolk DM, Carroll KC, Tang YW, editors. Microbiol Spectr. 2016;4(3). https:\/\/doi.org\/10.1128\/MICROBIOLSPEC.DMIH2-0011-2015.","DOI":"10.1128\/MICROBIOLSPEC.DMIH2-0011-2015"},{"issue":"4","key":"954_CR20","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1099\/JMM.0.000702","volume":"67","author":"I Engelmann","year":"2018","unstructured":"Engelmann I, Alidjinou EK, Lazrek M, et al. Comparison of two commercial quantitative PCR assays for EBV DNA detection and their correlation with the first WHO International Standard for EBV. J Med Microbiol. 2018;67(4):529\u201336. https:\/\/doi.org\/10.1099\/JMM.0.000702.","journal-title":"J Med Microbiol"},{"issue":"1","key":"954_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/FTD.0B013E318192304C","volume":"31","author":"RA Koster","year":"2009","unstructured":"Koster RA, Dijkers ECF, Uges DRA. Robust, high-throughput LC-MS\/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood. Ther Drug Monit. 2009;31(1):116\u201325. https:\/\/doi.org\/10.1097\/FTD.0B013E318192304C.","journal-title":"Ther Drug Monit"},{"key":"954_CR22","doi-asserted-by":"publisher","unstructured":"Zijp TR, Knobbe TJ, van Hateren K, et al. Expeditious quantification of plasma tacrolimus with liquid chromatography tandem mass spectrometry in solid organ transplantation. J Chromatogr B Anal Technol Biomed Life Sci. 2023;1222. https:\/\/doi.org\/10.1016\/J.JCHROMB.2023.123709.","DOI":"10.1016\/J.JCHROMB.2023.123709"},{"key":"954_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2023.464086","volume":"1702","author":"TR Zijp","year":"2023","unstructured":"Zijp TR, van Hateren K, Kuiper H, Jongedijk EM, Touw DJ. Ultra-high throughput dual channel liquid chromatography with tandem mass spectrometry for quantification of four immunosuppressants in whole blood for therapeutic drug monitoring. J Chromatogr A. 2023;1702: 464086. https:\/\/doi.org\/10.1016\/j.chroma.2023.464086.","journal-title":"J Chromatogr A"},{"key":"954_CR24","unstructured":"Weight-for-age. https:\/\/www.who.int\/tools\/child-growth-standards\/standards\/weight-for-age. Accessed 21 Apr 2024."},{"issue":"11","key":"954_CR25","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/S00147-002-0445-6","volume":"15","author":"T Orii","year":"2002","unstructured":"Orii T, Ohkohchi N, Satomi S, Hoshino Y, Kimura H. Decreasing the Epstein\u2013Barr virus load by adjusting the FK506 blood level. Transpl Int. 2002;15(11):529\u201334. https:\/\/doi.org\/10.1007\/S00147-002-0445-6.","journal-title":"Transpl Int"},{"key":"954_CR26","doi-asserted-by":"publisher","unstructured":"Meier UC, Cipian RC, Karimi A, Ramasamy R, Middeldorp JM. Cumulative roles for Epstein\u2013Barr virus, human endogenous retroviruses, and human herpes virus-6 in driving an inflammatory cascade underlying MS pathogenesis. Front Immunol. 2021;12. https:\/\/doi.org\/10.3389\/fimmu.2021.757302.","DOI":"10.3389\/fimmu.2021.757302"},{"issue":"3","key":"954_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.11406\/RINKETSU.58.189","volume":"58","author":"E Onozawa","year":"2017","unstructured":"Onozawa E, Shibayama H, Imadome KI, et al. Inflammatory cytokine production in chronic active Epstein\u2013Barr virus infection. Rinsho Ketsueki. 2017;58(3):189\u201396. https:\/\/doi.org\/10.11406\/RINKETSU.58.189.","journal-title":"Rinsho Ketsueki"},{"issue":"13","key":"954_CR28","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1096\/FJ.02-0195FJE","volume":"16","author":"R Jover","year":"2002","unstructured":"Jover R, Bort R, G\u00f3mez-Lech\u00f3n MJ, Castell JV. Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: molecular mechanism and transcription factors involved. FASEB J. 2002;16(13):1799\u2013801. https:\/\/doi.org\/10.1096\/FJ.02-0195FJE.","journal-title":"FASEB J"},{"issue":"6","key":"954_CR29","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/BCP.12038","volume":"75","author":"L Elens","year":"2013","unstructured":"Elens L, Hesselink DA, van Schaik RHN, van Gelder T. The CYP3A4*22 allele affects the predictive value of a pharmacogenetic algorithm predicting tacrolimus predose concentrations. Br J Clin Pharmacol. 2013;75(6):1545. https:\/\/doi.org\/10.1111\/BCP.12038.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"954_CR30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1517\/PHGS.5.3.243.29833","volume":"5","author":"HG Xie","year":"2004","unstructured":"Xie HG, Wood AJJ, Kim RB, Stein CM, Wilkinson GR. Genetic variability in CYP3A5 and its possible consequences. Pharmacogenomics. 2004;5(3):243\u201372. https:\/\/doi.org\/10.1517\/PHGS.5.3.243.29833.","journal-title":"Pharmacogenomics"},{"issue":"7","key":"954_CR31","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/PL00000257","volume":"50","author":"M Sukhai","year":"2001","unstructured":"Sukhai M, Yong A, Pak A, Piquette-Miller M. Decreased expression of P-glycoprotein in interleukin-1\u03b2 and interleukin-6 treated rat hepatocytes. Inflamm Res. 2001;50(7):362\u201370. https:\/\/doi.org\/10.1007\/PL00000257.","journal-title":"Inflamm Res"},{"issue":"3","key":"954_CR32","first-page":"359","volume":"7","author":"C Fernandez","year":"2004","unstructured":"Fernandez C, Buyse M, German-Fattal M, Gimenez F. Influence of the pro-inflammatory cytokines on P-glycoprotein expression and functionality. J Pharm Pharm Sci. 2004;7(3):359\u201371.","journal-title":"J Pharm Pharm Sci"},{"issue":"8","key":"954_CR33","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1023\/A:1018993312773","volume":"16","author":"K Yokogawa","year":"1999","unstructured":"Yokogawa K, Takahashi M, Tamai I, et al. P-glycoprotein-dependent disposition kinetics of tacrolimus: studies in mdr1a knockout mice. Pharm Res. 1999;16(8):1213\u20138. https:\/\/doi.org\/10.1023\/A:1018993312773.","journal-title":"Pharm Res"},{"issue":"2","key":"954_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.17219\/ACEM\/35254","volume":"25","author":"S Yigitaslan","year":"2016","unstructured":"Yigitaslan S, Erol K, Cengelli C. The effect of P-glycoprotein inhibition and activation on the absorption and serum levels of cyclosporine and tacrolimus in rats. Adv Clin Exp Med. 2016;25(2):237\u201342. https:\/\/doi.org\/10.17219\/ACEM\/35254.","journal-title":"Adv Clin Exp Med"},{"key":"954_CR35","doi-asserted-by":"publisher","unstructured":"Wacher VJ, Silverman JA, Zhang Y, Benet LZ. Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. J Pharm Sci. 1998;87(11):1322\u20131330. https:\/\/doi.org\/10.1021\/JS980082D.","DOI":"10.1021\/JS980082D"},{"issue":"2","key":"954_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5863\/1551-6776-24.2.138","volume":"24","author":"K Shoji","year":"2019","unstructured":"Shoji K, Miyairi I, Inoue E, Fukuda A, Sakamoto S, Kasahara M. Graft-to-recipient weight ratio associated with tacrolimus metabolism following pediatric living donor liver transplantations. J Pediatr Pharmacol Ther. 2019;24(2):138\u201347. https:\/\/doi.org\/10.5863\/1551-6776-24.2.138.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"954_CR37","doi-asserted-by":"publisher","unstructured":"Pinon M, De Nicol\u00f2 A, Pizzol A, et al. Early impact of donor CYP3A5 genotype and Graft-to-Recipient Weight Ratio on tacrolimus pharmacokinetics in pediatric liver transplant patients. Sci Rep. 2021;11(1):443. https:\/\/doi.org\/10.1038\/s41598-020-79574-7","DOI":"10.1038\/s41598-020-79574-7"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-025-00954-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13318-025-00954-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-025-00954-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T21:12:37Z","timestamp":1757193157000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13318-025-00954-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["954"],"URL":"https:\/\/doi.org\/10.1007\/s13318-025-00954-3","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"type":"print","value":"0378-7966"},{"type":"electronic","value":"2107-0180"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"26 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This is a retrospective and descriptive study. The Medical Ethics Review Board of the University Medical Center Groningen (METc UMCG) has confirmed that this study does not fall under the scope of the Medical Research Involving Human Subjects Act (WMO), and therefore, no WMO required (METc 2019\/621).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Due to the retrospective and descriptive nature of this study, the need for informed consent was waived by the UMCG METc (METc 2019\/621).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"No identifiable personal data is included in this study; therefore, consent for publication was not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The data used in this study is owned by the UMCG and is not publicly available. No custom code was developed for this study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Amber M. B. te Lintelo and Lisa F. van Wier contributed equally to this work. They were responsible for literature research, data extraction, data analysis, and writing the initial draft of the manuscript. Paola Mian, Daan J. Touw, and Hubert P. J. van der Doef contributed to the conceptualization of the study, data analysis, and writing and reviewing the manuscript. Coretta C. van Leer, Ren\u00e9 Scheenstra, Arno R. Bourgonje, and Jos. G. W. Kosterink contributed to reviewing the manuscript. All authors approved the final version of the manuscript.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contribution Statements"}}]}}